Clinical trial No longer in our active list Observational Ages 18 to 65

Evaluating blood flow and oxygen levels in the brain during laparoscopic gallbladder surgery

Official title: Evaluation of Cerebral Blood Flow and Cerebral Oxygenation With Transcranial Doppler and NIRS in Laparoscopic Cholecystectomy Cases

Run by Uludag University · NCT06036498 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing how blood flow and oxygen levels in the brain change during laparoscopic gallbladder surgery to see if certain techniques can help understand any risks involved.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUludag University
Academic / other
Locations1 site (Bursa, Nilufer)
Trial IDNCT06036498 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with an ASA classification of 1-3 scheduled for elective laparoscopic cholecystectomy.

Probably not a fit

Patients with ASA classification of 4 and above, those under 18 or over 65, and individuals with a history of cerebrovascular issues will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess changes in cerebral blood flow and oxygenation in patients undergoing laparoscopic cholecystectomy, particularly focusing on the effects of pneumoperitoneum. Researchers will utilize Near Infrared Spectrophotometry (NIRS) and Transcranial Doppler Ultrasonography (TCD) to monitor these changes. The study will compare the outcomes of both assessment methods to determine any significant differences. The findings could provide insights into the neurological risks associated with prolonged laparoscopic surgeries.

Why it matters

Potential benefit: If successful, this study could enhance patient safety by identifying potential neurological complications during laparoscopic surgeries.

How similar studies have gone: While the approach of using NIRS and TCD in this context is relatively novel, similar studies have shown promise in monitoring cerebral perfusion during surgical procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with American Society of Anesthesiology (ASA) 1-3 classification,
* Both male and female patients between the ages of 18 to 65,
* Patients scheduled for elective laparoscopic cholecystectomy.

Exclusion Criteria:

* American Society of Anesthesiology (ASA) 4 and above patient groups,
* Patients aged under 18 and over 65,
* Patients with a history of known previous cerebrovascular accident (CVA),
* Patients with follow-up due to Cerebrovascular Ischemic Brain Attack Syndrome (CIBAS),
* Patients diagnosed with Carotid Stenosis,
* Patients diagnosed with peripheral and central vascular diseases,
* Patients with general debilitation and extreme senility,
* Cases that require conversion to laparotomy during the intraoperative period.

Where it's running

  • Bursa Uludag University, Faculty of Medicine, Department of Anesthesiology and Reanimation
    Bursa, Nilufer, Turkey
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.